Bio-Techne TECH Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
Based on trailing twelve months.
The official record: Bio-Techne’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's return on equity?
- Bio-Techne (TECH) reported return on equity of 6.5% in Q1 2025.
- How has Bio-Techne's return on equity changed year-over-year?
- Bio-Techne's return on equity decreased by 37.2% year-over-year, from 10.4% to 6.5%.
- What is the long-term trend for Bio-Techne's return on equity?
- Over 2 years (2022 to 2024), Bio-Techne's return on equity has grown at a -29.3% compound annual growth rate (CAGR), from 16.7% to 8.3%.
- What does return on equity mean?
- How much profit the company earns on the money shareholders have invested.
- How do you interpret return on equity?
- Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
- How does return on equity compare across companies?
- Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.